ONTX - Onconova Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 514.86M
Enterprise Value 36.09M
Trailing P/E N/A
Forward P/E 1-0.67
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)18.19
Price/Book (mrq)N/A
Enterprise Value/Revenue 37.46
Enterprise Value/EBITDA 6-0.24

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-3,070.99%

Management Effectiveness

Return on Assets (ttm)-85.02%
Return on Equity (ttm)-1,185.27%

Income Statement

Revenue (ttm)817k
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)-93.30%
Gross Profit (ttm)5.55M
Net Income Avi to Common (ttm)-23.33M
Diluted EPS (ttm)-2.88
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.6M
Total Cash Per Share (mrq)0.77
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.97
Book Value Per Share (mrq)-0.70

Cash Flow Statement

Operating Cash Flow (ttm)-23.51M
Levered Free Cash Flow (ttm)-12.69M

Trading Information

Stock Price History

Beta 1.35
52-Week Change 3-38.77%
S&P500 52-Week Change 317.21%
52 Week High 33.88
52 Week Low 31.21
50-Day Moving Average 31.71
200-Day Moving Average 31.89

Share Statistics

Avg Vol (3 month) 3193.81k
Avg Vol (10 day) 3110.55k
Shares Outstanding 510.77M
Float 6.15M
% Held by Insiders 119.55%
% Held by Institutions 125.49%
Shares Short 3342.5k
Short Ratio 33.1
Short % of Float 37.05%
Shares Short (prior month) 3344.39k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3Jun 1, 2016